SCHEMBL8633669

SCHEMBL8633669

CC(=O)C(Oc1ccccc1)C(=O)ON1CCN(c2ccncc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 6/20 0.44
TSHR P16473 4/20 0.44
HIF1A Q16665 4/20 0.44
CYP2D6 P10635 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
CYP2C19 P33261 4/20 0.41
CYP3A4 P08684 3/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ROCK2 O75116 1/20 0.41
HRH3 Q9Y5N1 4/20 0.40
HRH2 P25021 1/20 0.39
HRH1 P35367 1/20 0.39
CYP1A2 P05177 2/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8631977 0.89 ROCK2 (0.42) CYP2C9TSHRHIF1ACYP2D6SMN1; SMN2
SCHEMBL8630734 0.89 ROCK2 (0.52) CYP2D6SMN1; SMN2ALDH1A1ITGB3ITGA2B
SCHEMBL8633528 0.86 AOC3 (0.39) TSHRALDH1A1MAPK1MAPT
SCHEMBL8634919 0.85 CYP2C9 (0.37) CYP2C9TSHRHIF1ACYP2D6SMN1; SMN2
SCHEMBL8632221 0.85 TSHR (0.40) CYP2C9TSHRHIF1AALDH1A1ITGB3
SCHEMBL8632788 0.84 MAPT (0.37) TSHRALDH1A1MAPK1GAAKDM4E
SCHEMBL8632956 0.84 CYP2C9 (0.38) CYP2C9TSHRHIF1ACYP2D6SMN1; SMN2
SCHEMBL8636239 0.83 CHRM1 (0.39) CYP2C9TSHRHIF1AALDH1A1ITGB3
Hydrochloric Acid SCHEMBL8681516 0.83 CYP2C9 (0.38) CYP2C9TSHRHIF1ACYP2D6SMN1; SMN2
SCHEMBL8634776 0.81 AOC3 (0.38) CYP2C9TSHRHIF1AALDH1A1ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed
US-5728701-A INHIBIT PLATELET AGGREGATION ZENECA LIMITED (GB) 1998-03-17 US disclosed